Howard Marks’s Mesoblast MESO Stock Holding History

Howard Marks’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-179,593	Closed	-$3.56M	–	173
2024 Q4	$3.56M	Buy	+179,593	New	+$1.99M	0.06%	121

Other funds holding MESO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Howard Marks's MESO Position: Q1 2025 in Review

Howard Marks sold out of Mesoblast (MESO) in Q1 2025, closing a stake of 179,593 shares — an estimated $3.56M sold.

Howard Marks first reported a position in MESO in Q4 2024 and held it in 1 quarter. The position peaked at $3.56M in Q4 2024. 68 funds tracked by Wall St. Rank hold MESO as of Q1 2025.

Howard Marks reported no remaining Mesoblast position as of Q1 2025 after selling out during the quarter.
Howard Marks sold 179,593 Mesoblast shares in Q1 2025, an estimated $3.56M.
Howard Marks first reported a position in Mesoblast in Q4 2024 and held it in 1 quarter.
Howard Marks's Mesoblast position peaked at $3.56M in Q4 2024.
68 funds tracked by Wall St. Rank held Mesoblast as of Q1 2025.

Based on Oaktree Capital Management's 13F filing for Q1 2025, filed 15 May 2025.